These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16403839)

  • 1. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
    Vaziri ND
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F262-72. PubMed ID: 16403839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of dysregulation of lipid metabolism in chronic renal failure.
    Vaziri ND
    Semin Dial; 2009; 22(6):644-51. PubMed ID: 20017835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure.
    Liang K; Vaziri ND
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
    Vaziri ND; Liang K; Parks JS
    Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
    Vaziri ND
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
    Vaziri ND; Liang K
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
    Vaziri ND; Kim CH; Dang B; Zhan CD; Liang K
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F90-4. PubMed ID: 15010358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid disorders and their relevance to outcomes in chronic kidney disease.
    Vaziri ND; Norris K
    Blood Purif; 2011; 31(1-3):189-96. PubMed ID: 21228589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of dyslipidemia of chronic renal failure.
    Vaziri ND; Moradi H
    Hemodial Int; 2006 Jan; 10(1):1-7. PubMed ID: 16441821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
    Mori Y; Hirano T; Nagashima M; Shiraishi Y; Fukui T; Adachi M
    Metabolism; 2007 Dec; 56(12):1714-8. PubMed ID: 17998026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and renal failure: similarities and differences.
    Kaysen GA
    Panminerva Med; 2006 Sep; 48(3):151-64. PubMed ID: 17122751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders in high-density metabolism with insulin resistance and chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2007 Jan; 17(1):4-8. PubMed ID: 17198924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anomalies of lipoprotein metabolism in chronic renal insufficiency].
    Lacour B; Massy ZA; Jungers P; Drueke T
    Nephrologie; 1993; 14(2):75-90. PubMed ID: 8327031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid abnormalities associated with end-stage renal disease.
    Liu J; Rosner MH
    Semin Dial; 2006; 19(1):32-40. PubMed ID: 16423180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.